Key result
Short-term intravenous sodium nitrite infusion at /kg/min increased left ventricular stroke volume from 43.22 to 51.84 mL in patients with severe chronic heart failure.
Why the study?
Does short-term intravenous sodium nitrite infusion improve cardiac and pulmonary hemodynamics in patients with severe chronic heart failure?
Does short-term intravenous sodium nitrite infusion improve cardiac and pulmonary hemodynamics in patients with severe chronic heart failure?
Short-term intravenous sodium nitrite infusion improves cardiac output and reduces right-sided filling pressures in severe chronic heart failure, suggesting potential utility in decompensated HF.
Answers are grounded in this paper and cite their sources.
Sodium nitrite shows hemodynamic promise in stable HF; leaves open its utility and safety in acute decompensated HF pending larger trials.
BACKGROUND: Nitrite exhibits hypoxia-dependent vasodilator properties, selectively dilating capacitance vessels in healthy subjects. Unlike organic nitrates, it seems not to be subject to the development of tolerance. Currently, therapeutic options for decompensated heart failure (HF) are limited. We hypothesized that by preferentially dilating systemic capacitance and pulmonary resistance vessels although only marginally dilating resistance vessels, sodium nitrite (NaNO2) infusion would increase cardiac output but reduce systemic arterial blood pressure only modestly. We therefore undertook a first-in-human HF proof of concept/safety study, evaluating the hemodynamic effects of short-term NaNO2 infusion. METHODS AND RESULTS: Twenty-five patients with severe chronic HF were recruited. Eight received short-term (5 minutes) intravenous NaNO2 at 10 μg/kg/min and 17 received 50 μg/kg/min with measurement of cardiac hemodynamics. During infusion of 50 μg/kg/min, left ventricular stroke volume increased (from 43.22±21.5 to 51.84±23.6 mL; P=0.003), with marked falls in pulmonary vascular resistance (by 29%; P=0.03) and right atrial pressure (by 40%; P=0.007), but with only modest falls in mean arterial blood pressure (by 4 mm Hg; P=0.004). The increase in stroke volume correlated with the increase in estimated trans-septal gradient (=pulmonary capillary wedge pressure-right atrial pressure; r=0.67; P=0.003), suggesting relief of diastolic ventricular interaction as a contributory mechanism. Directionally similar effects were observed for the above hemodynamic parameters with 10 μg/kg/min; this was significant only for stroke volume, not for other parameters. CONCLUSIONS: This first-in-human HF efficacy/safety study demonstrates an attractive profile during short-term systemic NaNO2 infusion that may be beneficial in decompensated HF and warrants further evaluation with longer infusion regimens.
No takes yet. Share an insight, caveat, or question.
Ormerod et al. (2015) studied Severe chronic heart failure (n=25). Intravenous sodium nitrite (NaNO2) vs. Baseline was evaluated on Left ventricular stroke volume (p=0.003). Short-term intravenous sodium nitrite infusion at /kg/min increased left ventricular stroke volume from 43.22 to 51.84 mL in patients with severe chronic heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: